{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:22:35Z","timestamp":1740126155045,"version":"3.37.3"},"reference-count":6,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T00:00:00Z","timestamp":1693958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,16]]},"DOI":"10.1093\/bjd\/ljad322","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T10:11:16Z","timestamp":1693995076000},"page":"e100-e101","source":"Crossref","is-referenced-by-count":0,"title":["The limitations of persistence as a measure of efficacy of biologic therapies"],"prefix":"10.1093","volume":"189","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5491-149X","authenticated-orcid":false,"given":"Robert S","family":"Stern","sequence":"first","affiliation":[{"name":"Department of Dermatology, Beth Israel Deaconess Medical Center, Harvard Medical School , Boston, MA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,9,6]]},"reference":[{"key":"2023111618480511800_ljad322-B1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/bjd\/ljad248","article-title":"Persistence of second-line biologics in psoriasis after first-line biologic failure: a nationwide cohort study from the French health insurance database (SNDS)","volume":"189","author":"Marcombes","year":"2023","journal-title":"Br J Dermatol"},{"key":"2023111618480511800_ljad322-B2","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.jid.2023.03.1660","article-title":"First-line persistence of biologics in psoriasis from a cohort based on French medico-administrative data","volume":"143","author":"Marcombes","year":"2023","journal-title":"J Invest Dermatol"},{"key":"2023111618480511800_ljad322-B3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/jamadermatol.2022.0364","article-title":"Long-term persistence of first-line biologics for patients with psoriasis and psoriatic arthritis in the French health insurance database","volume":"158","author":"Pina Vegas","year":"2022","journal-title":"JAMA Dermatol"},{"key":"2023111618480511800_ljad322-B4","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/bjd.16809","article-title":"Persistence of treatment with biologics for patients with psoriasis: a real-world analysis of 16 545 biologic-na\u00efve patients from the French National Health Insurance database (SNIIRAM)","volume":"180","author":"Sbidian","year":"2019","journal-title":"Br J Dermatol"},{"key":"2023111618480511800_ljad322-B5","first-page":"1482","article-title":"Persistence of treatment with conventional systemic agents for patients with psoriasis: a real-world analysis of 73 168 new users from the French National Health Insurance database","volume":"182","author":"Bergqvist","year":"2023","journal-title":"Br J Dermatol"},{"key":"2023111618480511800_ljad322-B6","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/bjd.18047","article-title":"Persistence of apremilast in moderate-to-severe psoriasis: a real-world analysis of 14 147 apremilast- and methotrexate-naive patients in the French National Health Insurance database","volume":"182","author":"Sbidian","year":"2020","journal-title":"Br J Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljad322\/52137857\/ljad322.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/189\/6\/e100\/53474825\/ljad322.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/189\/6\/e100\/53474825\/ljad322.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T18:49:36Z","timestamp":1700160576000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/189\/6\/e100\/7261341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,6]]},"references-count":6,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,9,6]]},"published-print":{"date-parts":[[2023,11,16]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljad322","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"type":"print","value":"0007-0963"},{"type":"electronic","value":"1365-2133"}],"subject":[],"published-other":{"date-parts":[[2023,12]]},"published":{"date-parts":[[2023,9,6]]}}}